DLC and DPAC Applaud House Appropriations Committee for Acting to Protect Access to Lifesaving Diabetes Technology

Back to News

DLC and DPAC Applaud House Appropriations Committee for Acting to Protect Access to Lifesaving Diabetes Technology

‍

WASHINGTON, D.C., June 9, 2026

The Diabetes Patient Advocacy Coalition and Diabetes Leadership Council applaud the House Appropriations Committee for taking an important step in protecting access to lifesaving technology for people with diabetes. Today, the committee approved its draft fiscal year (FY) 2027 Labor, HHS, Education Appropriations bill, sending it to the full House of Representatives for consideration. The report accompanying the bill directs the Centers for Medicare and Medicaid Services (CMS) to ensure Medicare beneficiaries with diabetes have reliable access to lifesaving diabetes technology while continuing to address waste, fraud and abuse within the Medicare program.

In December 2025, despite significant concerns raised by thousands of people with diabetes, DLC, DPAC and other stakeholders, CMS finalized a policy that would include continuous glucose monitors (CGMs) and insulin pumps in the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program. DLC and DPAC remain concerned that this policy will create unnecessary and potentially dangerous disruptions in access to the technologies that people with diabetes rely on every day to administer insulin and manage their blood glucose levels.

DLC and DPAC support efforts to ensure Medicare coverage policies are aligned with current clinical standards of care while safeguarding taxpayer resources and protecting against waste, fraud and abuse. We are encouraged that the House Appropriations Committee recognized the need to closely examine the impact of CMS’s policy changes on patient access to medically appropriate diabetes technologies.

DLC and DPAC look forward to working with Congress and CMS to ensure that Medicare beneficiaries maintain access to the diabetes technologies that are essential to their health, safety, and quality of life.

Download PDF
News
>

DLC and DPAC Applaud House Appropriations Committee for Acting to Protect Access to Lifesaving Diabetes Technology

‍

WASHINGTON, D.C., June 9, 2026

The Diabetes Patient Advocacy Coalition and Diabetes Leadership Council applaud the House Appropriations Committee for taking an important step in protecting access to lifesaving technology for people with diabetes. Today, the committee approved its draft fiscal year (FY) 2027 Labor, HHS, Education Appropriations bill, sending it to the full House of Representatives for consideration. The report accompanying the bill directs the Centers for Medicare and Medicaid Services (CMS) to ensure Medicare beneficiaries with diabetes have reliable access to lifesaving diabetes technology while continuing to address waste, fraud and abuse within the Medicare program.

In December 2025, despite significant concerns raised by thousands of people with diabetes, DLC, DPAC and other stakeholders, CMS finalized a policy that would include continuous glucose monitors (CGMs) and insulin pumps in the Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program. DLC and DPAC remain concerned that this policy will create unnecessary and potentially dangerous disruptions in access to the technologies that people with diabetes rely on every day to administer insulin and manage their blood glucose levels.

DLC and DPAC support efforts to ensure Medicare coverage policies are aligned with current clinical standards of care while safeguarding taxpayer resources and protecting against waste, fraud and abuse. We are encouraged that the House Appropriations Committee recognized the need to closely examine the impact of CMS’s policy changes on patient access to medically appropriate diabetes technologies.

DLC and DPAC look forward to working with Congress and CMS to ensure that Medicare beneficiaries maintain access to the diabetes technologies that are essential to their health, safety, and quality of life.